Elevation of circulating TNF receptor 2 in cancer: A systematic meta-analysis for its potential as a diagnostic cancer biomarker
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Elevation of circulating TNF receptor 2 in cancer: A systematic meta-analysis for its potential as a diagnostic cancer biomarker
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 13, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2022-11-16
DOI
10.3389/fimmu.2022.918254
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Systemic inflammation and risk of all-cause mortality after invasive breast cancer diagnosis among Hispanic and non-Hispanic white women from New Mexico
- (2022) Avonne E. Connor et al. Cancer Epidemiology
- Pre‐diagnostic levels of sVEGFR2, sTNFR2, sIL‐2Rα and sIL‐6R are associated with glioma risk: A nested case–control study of repeated samples
- (2022) Wendy Yi‐Ying Wu et al. Cancer Medicine
- Targeting TNFR2 in Cancer: All Roads Lead to Rome
- (2022) Jingchao Bai et al. Frontiers in Immunology
- Targeting TNFR2: A Novel Breakthrough in the Treatment of Cancer
- (2022) Muchun Li et al. Frontiers in Oncology
- TNFα priming through its interaction with TNFR2 enhances endothelial progenitor cell immunosuppressive effect: new hope for their widespread clinical application
- (2021) Mahsa Nouri Barkestani et al. Cell Communication and Signaling
- Association between pre-diagnostic circulating adipokines and colorectal cancer and adenoma in the CLUE II cohort
- (2021) Michael T. Marrone et al. CANCER CAUSES & CONTROL
- The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
- (2021) Matthew J Page et al. BMJ-British Medical Journal
- Prognostic Value of TNFR2 and STAT3 among High-Grade Serous Ovarian Cancer Survivors According to Platinum Sensitivity
- (2021) Janisha Silva Raju et al. Diagnostics
- Conducting proportional meta-analysis in different types of systematic reviews: a guide for synthesisers of evidence
- (2021) Timothy Hugh Barker et al. BMC Medical Research Methodology
- Tumor-Induced Inflammatory Cytokines and the Emerging Diagnostic Devices for Cancer Detection and Prognosis
- (2021) Apriliana E. R. Kartikasari et al. Frontiers in Oncology
- Differences and similarities between mesenchymal stem cell and endothelial progenitor cell immunoregulatory properties against T cells
- (2021) Mehdi Razazian et al. World Journal of Stem Cells
- The TNF-α/TNFR2 Pathway: Targeting a Brake to Release the Anti-tumor Immune Response
- (2021) Audrey Moatti et al. Frontiers in Cell and Developmental Biology
- Elevated Interleukin-6 Levels in the Circulation and Peritoneal Fluid of Patients with Ovarian Cancer as a Potential Diagnostic Biomarker: A Systematic Review and Meta-Analysis
- (2021) Hina Amer et al. Journal of Personalized Medicine
- Circulating Tumor Necrosis Factor Receptors: A Potential Biomarker for the Progression of Diabetic Kidney Disease
- (2020) Maki Murakoshi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Assessment of the risk of tumor progression in different subtypes of breast cancer.
- (2020) Liubov Yu Vladimirova et al. JOURNAL OF CLINICAL ONCOLOGY
- C-reactive protein at 1 month after treatment of nivolumab as a predictive marker of efficacy in advanced renal cell carcinoma
- (2020) Go Noguchi et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Impact of age‐, cancer‐, and treatment‐driven inflammation on T cell function and immunotherapy
- (2020) Kylie M. Quinn et al. JOURNAL OF LEUKOCYTE BIOLOGY
- TNFα-TNFR2 signaling pathway in control of the neural stem/progenitor cell immunosuppressive effect: Different experimental approaches to assess this hypothetical mechanism behind their immunological function
- (2020) Sara Shamdani et al. Stem Cell Research & Therapy
- TNFα/TNFR2 signaling pathway: an active immune checkpoint for mesenchymal stem cell immunoregulatory function
- (2020) Ghada Beldi et al. Stem Cell Research & Therapy
- Regulatory T cell induction by mesenchymal stem cells depends on the expression of TNFR2 by T cells
- (2020) Sina Naserian et al. Stem Cell Research & Therapy
- Accumulation of TNFR2-expressing regulatory T cells in malignant pleural effusion of lung cancer patients is associated with poor prognosis
- (2020) Lin-Lin Ye et al. Annals of Translational Medicine
- Consumption of whole grain/bran rye instead of refined wheat decrease concentrations of TNF-R2, e-selectin, and endostatin in an exploratory study in men with prostate cancer
- (2019) Galia Zamaratskaia et al. CLINICAL NUTRITION
- Expression of tumor necrosis factor receptor 2 in human non-small cell lung cancer and its role as a potential prognostic biomarker
- (2019) Yan Wen Zhang et al. Thoracic Cancer
- Exploration of potential prognostic biomarkers in aflibercept plus FOLFIRI in Japanese patients with metastatic colorectal cancer
- (2019) Tetsuya Hamaguchi et al. CANCER SCIENCE
- Editorial: The Role of TNF-TNFR2 Signal in Immunosuppressive Cells and Its Therapeutic Implications
- (2019) Xin Chen et al. Frontiers in Immunology
- The reciprocal interaction between tumor cells and activated fibroblasts mediated by TNF-α/IL-33/ST2L signaling promotes gastric cancer metastasis
- (2019) Quan Zhou et al. ONCOGENE
- Plasma inflammatory biomarkers and modifiable lifestyle factors associated with colorectal cancer risk
- (2019) Jimi Kim et al. CLINICAL NUTRITION
- Circulating inflammatory proteins and gallbladder cancer: Potential for risk stratification to improve prioritization for cholecystectomy in high-risk regions
- (2018) Jill Koshiol et al. Cancer Epidemiology
- TNF-R2 in tumor microenvironment as prognostic factor in epithelial ovarian cancer
- (2018) Rosekeila Simões Nomelini et al. CLINICAL AND EXPERIMENTAL MEDICINE
- High expression of tumor necrosis factor receptor 2 in tissue is associated with progression and prognosis of esophageal squamous cell carcinoma
- (2018) Zifeng Liu et al. HUMAN PATHOLOGY
- Clinical significance of tumor necrosis factor receptor 2 in middle and lower thoracic esophageal squamous cell carcinoma
- (2018) Dong Yang et al. Oncology Letters
- TNF Receptor 2 Makes Tumor Necrosis Factor a Friend of Tumors
- (2018) Yuqiao Sheng et al. Frontiers in Immunology
- Prediagnostic circulating markers of inflammation and risk of oesophageal adenocarcinoma: a study within the National Cancer Institute Cohort Consortium
- (2018) Michael B Cook et al. GUT
- Lab-on-a-Chip Platforms for Detection of Cardiovascular Disease and Cancer Biomarkers
- (2017) Jiandong Wu et al. SENSORS
- TNFR2: A Novel Target for Cancer Immunotherapy
- (2017) Éva S. Vanamee et al. TRENDS IN MOLECULAR MEDICINE
- Aberrant frequency of TNFR2+ Treg and related cytokines in patients with CIN and cervical cancer
- (2017) Teng Zhang et al. Oncotarget
- Interleukin 6 Present in Inflammatory Ascites from Advanced Epithelial Ovarian Cancer Patients Promotes Tumor Necrosis Factor Receptor 2-Expressing Regulatory T Cells
- (2017) Nirmala Chandralega Kampan et al. Frontiers in Immunology
- TNFR2/BIRC3-TRAF1 signaling pathway as a novel NK cell immune checkpoint in cancer
- (2017) Alexandre Ivagnès et al. OncoImmunology
- Soluble tumour necrosis factor receptor type II and survival in colorectal cancer
- (2016) Ana Babic et al. BRITISH JOURNAL OF CANCER
- Inflammatory biomarkers, aspirin, and risk of colorectal cancer: Findings from the physicians’ health study
- (2016) Chul Kim et al. Cancer Epidemiology
- Inflammatory Markers of CRP, IL6, TNF , and Soluble TNFR2 and the Risk of Ovarian Cancer: A Meta-analysis of Prospective Studies
- (2016) F. Zeng et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Correlates of Protection against Influenza in the Elderly: Results from an Influenza Vaccine Efficacy Trial
- (2016) Andrew J. Dunning et al. Clinical and Vaccine Immunology
- Correlation of higher levels of soluble TNF-R1 with a shorter survival, independent of age, in recurrent glioblastoma
- (2016) Manmeet S. Ahluwalia et al. JOURNAL OF NEURO-ONCOLOGY
- The heterogeneity statistic I2 can be biased in small meta-analyses
- (2015) Paul T von Hippel BMC Medical Research Methodology
- Expression of TNFR2 by regulatory T cells in peripheral blood is correlated with clinical pathology of lung cancer patients
- (2015) Fan Yan et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Plasma Inflammatory Markers and Risk of Advanced Colorectal Adenoma in Women
- (2015) M. Song et al. Cancer Prevention Research
- Shedding of TNF receptor 2 by effector CD8+ T cells by ADAM17 is important for regulating TNF-α availability during influenza infection
- (2015) Matthew P. DeBerge et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Circulating Inflammation Markers, Risk of Lung Cancer, and Utility for Risk Stratification
- (2015) Meredith S. Shiels et al. JNCI-Journal of the National Cancer Institute
- Circulating Inflammation Markers, Risk of Lung Cancer, and Utility for Risk Stratification
- (2015) Meredith S. Shiels et al. JNCI-Journal of the National Cancer Institute
- Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range
- (2015) Xiang Wan et al. BMC Medical Research Methodology
- Elevated serum sCD23 and sCD30 up to two decades prior to diagnosis associated with increased risk of non-Hodgkin lymphoma
- (2015) M P Purdue et al. LEUKEMIA
- A case–control study of pre-operative levels of serum neutrophil gelatinase-associated lipocalin and other potential inflammatory markers in colorectal cancer
- (2014) Laurence Duvillard et al. BMC CANCER
- Cutting Edge: TNFR-Shedding by CD4+CD25+ Regulatory T Cells Inhibits the Induction of Inflammatory Mediators
- (2014) G. J. D. van Mierlo et al. JOURNAL OF IMMUNOLOGY
- A four-marker signature of TNF-RII, TGF-α, TIMP-1 and CRP is prognostic of worse survival in high-risk surgically resected melanoma
- (2014) Ahmad A Tarhini et al. Journal of Translational Medicine
- A Prospective Study of Circulating C-Reactive Protein, Interleukin-6, and Tumor Necrosis Factor α Receptor 2 Levels and Risk of Ovarian Cancer
- (2013) Elizabeth M. Poole et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- A prospective study of 67 serum immune and inflammation markers and risk of non-Hodgkin lymphoma
- (2013) M. P. Purdue et al. BLOOD
- A prospective study of plasma inflammatory markers and risk of colorectal cancer in men
- (2013) M Song et al. BRITISH JOURNAL OF CANCER
- Circulating Soluble Cytokine Receptors and Colorectal Cancer Risk
- (2013) G. Y. F. Ho et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Adipocytokines, Inflammation, and Breast Cancer Risk in Postmenopausal Women: A Prospective Study
- (2013) A. L. Gross et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Serum level of soluble tumor necrosis factor receptor 2 is associated with the outcome of patients with diffuse large B-cell lymphoma treated with the R-CHOP regimen
- (2013) Nobuhiko Nakamura et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- TNFR2 Is Critical for the Stabilization of the CD4+Foxp3+ Regulatory T Cell Phenotype in the Inflammatory Environment
- (2013) X. Chen et al. JOURNAL OF IMMUNOLOGY
- Transmembrane TNF- Promotes Suppressive Activities of Myeloid-Derived Suppressor Cells via TNFR2
- (2013) X. Hu et al. JOURNAL OF IMMUNOLOGY
- Pro-Inflammatory Adipokines as Predictors of Incident Cancers in a Chinese Cohort of Low Obesity Prevalence in Hong Kong
- (2013) Chun-Yip Yeung et al. PLoS One
- Higher serum levels of tumour necrosis factor and its soluble receptors are associated with ovarian tumours
- (2012) Aleksandra Mielczarek-Palacz et al. Archives of Medical Science
- Inflammation marker and risk of pancreatic cancer: a nested case–control study within the EPIC cohort
- (2012) V A Grote et al. BRITISH JOURNAL OF CANCER
- Circulating Levels of TNF Receptor II Are Prognostic for Patients with Peripheral T-cell Non-Hodgkin Lymphoma
- (2012) C. Heemann et al. CLINICAL CANCER RESEARCH
- TNF signaling drives myeloid-derived suppressor cell accumulation
- (2012) Xueqiang Zhao et al. JOURNAL OF CLINICAL INVESTIGATION
- Increased tumor necrosis factor receptor 1 expression in human colorectal adenomas
- (2012) Kunihiro Hosono WORLD JOURNAL OF GASTROENTEROLOGY
- Circulating Inflammation Markers and Risk of Epithelial Ovarian Cancer
- (2011) T. V. Clendenen et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Prediagnostic Serum Levels of Cytokines and Other Immune Markers and Risk of Non-Hodgkin Lymphoma
- (2011) M. P. Purdue et al. CANCER RESEARCH
- Circulating cytokines and risk of B-cell non-Hodgkin lymphoma: a prospective study
- (2010) Yian Gu et al. CANCER CAUSES & CONTROL
- Tumor necrosis factor-alpha and its receptors in epithelial ovarian cancer.
- (2010) Bozena Dobrzycka et al. FOLIA HISTOCHEMICA ET CYTOBIOLOGICA
- Inflammatory Markers Are Associated With Risk of Colorectal Cancer and Chemopreventive Response to Anti-Inflammatory Drugs
- (2010) Andrew T. Chan et al. GASTROENTEROLOGY
- Tumor necrosis factor (TNF)-α, soluble TNF receptors and endometrial cancer risk: The EPIC study
- (2010) Laure Dossus et al. INTERNATIONAL JOURNAL OF CANCER
- A basic introduction to fixed-effect and random-effects models for meta-analysis
- (2010) Michael Borenstein et al. Research Synthesis Methods
- TNF: A master switch for inflammation to cancer
- (2008) Gautam Sethi Frontiers in Bioscience-Landmark
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now